John Militello Rocket Pharmaceuticals, Inc. (RCKT) insider trading activity

John Militello is of ROCKET PHARMACEUTICALS, INC.. Currently has a direct ownership of 95,924 shares of RCKT, which is worth approximately $308,875. The most recent transaction as insider was on Sep 08, 2025, when has been sold 40,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 95.9K

49.82% 3M change

86.44% 12M change

Total Value Held $308,875

John Militello Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 08 2025	BUY Grant, award, or other acquisition	-	40,000 Added 29.43%	95,924 Common Stock
Aug 19 2025	SELL Open market or private sale	$1,083 $3.0 p/Share	361 Reduced 0.64%	55,924 Common Stock
Aug 18 2025	SELL Open market or private sale	$2,138 $3.06 p/Share	699 Reduced 1.23%	56,285 Common Stock
Aug 14 2025	SELL Open market or private sale	$21,269 $3.02 p/Share	7,043 Reduced 11.0%	56,984 Common Stock
May 20 2025	SELL Open market or private sale	$2,302 $6.45 p/Share	357 Reduced 0.55%	64,027 Common Stock
May 16 2025	SELL Open market or private sale	$4,277 $6.53 p/Share	655 Reduced 1.01%	64,384 Common Stock
Apr 22 2025	SELL Open market or private sale	$5,140 $7.16 p/Share	718 Reduced 1.09%	65,039 Common Stock
Feb 21 2025	SELL Open market or private sale	$28,957 $10.58 p/Share	2,737 Reduced 4.0%	65,757 Common Stock
Feb 11 2025	BUY Grant, award, or other acquisition	-	20,080 Added 22.67%	68,494 Common Stock
Jan 23 2025	SELL Open market or private sale	$9,300 $10.38 p/Share	896 Reduced 1.82%	48,414 Common Stock
Nov 21 2024	SELL Open market or private sale	$15,973 $13.05 p/Share	1,224 Reduced 2.42%	49,310 Common Stock
Oct 31 2024	SELL Open market or private sale	$15,240 $16.62 p/Share	917 Reduced 1.78%	50,534 Common Stock
Aug 16 2024	SELL Open market or private sale	$19,684 $18.5 p/Share	1,064 Reduced 2.03%	51,451 Common Stock
Jul 22 2024	SELL Open market or private sale	$18,692 $23.02 p/Share	812 Reduced 1.52%	52,515 Common Stock
May 16 2024	SELL Open market or private sale	$25,194 $23.35 p/Share	1,079 Reduced 1.98%	53,327 Common Stock
Apr 22 2024	SELL Open market or private sale	$19,050 $22.87 p/Share	833 Reduced 1.51%	54,406 Common Stock
Mar 21 2024	SELL Open market or private sale	$69,969 $28.1 p/Share	2,490 Reduced 4.31%	55,239 Common Stock
Feb 29 2024	SELL Open market or private sale	$298,400 $29.84 p/Share	10,000 Reduced 31.73%	21,517 Common Stock
Feb 29 2024	BUY Exercise of conversion of derivative security	$125,500 $12.55 p/Share	10,000 Added 24.09%	31,517 Common Stock
Feb 16 2024	SELL Open market or private sale	$96,621 $29.84 p/Share	3,238 Reduced 19.7%	13,195 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	8,322 Added 27.89%	21,517 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	-	6,274 Added 27.63%	16,433 Common Stock
Jan 22 2024	SELL Open market or private sale	$17,353 $27.2 p/Share	638 Reduced 5.91%	10,159 Common Stock
Jan 18 2024	BUY Exercise of conversion of derivative security	-	1,586 Added 12.81%	10,797 Common Stock
Nov 14 2023	BUY Exercise of conversion of derivative security	-	725 Added 7.1%	9,485 Common Stock

John Militello

Cranbury, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCKT shares.

Notify only if

Value

Insider Trading

Get notified when an Rocket Pharmaceuticals, Inc. insider buys or sells RCKT shares.

Notify only if

Operation

Value

Type

News

Receive news related to ROCKET PHARMACEUTICALS, INC.

Track Activities on RCKT

Account